tailieunhanh - A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: Real-world practice

For the first-line treatment of KRAS mutant non-small cell lung cancer (NSCLC) patients, immunotherapy or platinum-based chemotherapy are the main treatment method. Here, we investigated the clinical efcacy and prognosis those two regimens as first-line treatment in real-world practice. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN